TWO SIGMA ADVISERS, LP - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 113 filers reported holding MERSANA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$458,089
-75.9%
360,700
-37.6%
0.00%
-80.0%
Q2 2023$1,901,949
-42.5%
578,100
-28.1%
0.01%
-44.4%
Q1 2023$3,306,495
-46.4%
804,500
-23.6%
0.01%
-47.1%
Q4 2022$6,172,338
-18.3%
1,053,300
-5.8%
0.02%
-22.7%
Q3 2022$7,556,000
+50.5%
1,117,700
+2.9%
0.02%
+57.1%
Q2 2022$5,021,000
-6.8%
1,086,700
-19.5%
0.01%0.0%
Q1 2022$5,385,000
-17.6%
1,349,500
+28.5%
0.01%
-12.5%
Q4 2021$6,532,000
+9.9%
1,050,200
+66.7%
0.02%
+6.7%
Q3 2021$5,941,000
-22.9%
630,000
+11.0%
0.02%
-25.0%
Q2 2021$7,708,000
-18.8%
567,600
-3.3%
0.02%
-23.1%
Q1 2021$9,493,000
-27.2%
586,700
+19.8%
0.03%
-25.7%
Q4 2020$13,036,000
+137.7%
489,900
+66.3%
0.04%
+118.8%
Q3 2020$5,484,000
+92.8%
294,500
+142.2%
0.02%
+100.0%
Q2 2020$2,845,000
+848.3%
121,600
+136.1%
0.01%
+700.0%
Q1 2020$300,000
+40.2%
51,500
+37.7%
0.00%
Q4 2019$214,000
+275.4%
37,400
+4.2%
0.00%
Q3 2019$57,000
+21.3%
35,900
+212.2%
0.00%
Q2 2019$47,00011,5000.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders